flupirtine has been researched along with Aging in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bian, WJ; Chen, C; Damonte, VM; de Lecea, L; Kauer, JA; Kebschull, JM; Li, SB; Mourrain, P; Pattni, R; Purmann, C; Scherrer, G; Urban, AE; Wang, GX; Yamaguchi, H | 1 |
de Mey, C; Deliyska, B; Gatchev, E; Terhaag, B | 1 |
Böhm, M; Meesters, E; Meinhardt, A; Müller, WE; Pergande, G; Perovic, S | 1 |
1 trial(s) available for flupirtine and Aging
Article | Year |
---|---|
Effects of advanced age and renal dysfunction on the single- and repeated-dose pharmacokinetics of modified-release flupirtine.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aging; Aminopyridines; Analgesics; Area Under Curve; Biomarkers; Creatinine; Delayed-Action Preparations; Drug Administration Schedule; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Severity of Illness Index; Young Adult | 2015 |
2 other study(ies) available for flupirtine and Aging
Article | Year |
---|---|
Hyperexcitable arousal circuits drive sleep instability during aging.
Topics: Aging; Aminopyridines; Animals; CRISPR-Cas Systems; Electroencephalography; Electromyography; Female; Hypothalamic Area, Lateral; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mice; Narcolepsy; Nerve Tissue Proteins; Neural Pathways; Neurons; Optogenetics; Orexins; Patch-Clamp Techniques; RNA-Seq; Sleep; Sleep Deprivation; Sleep Quality; Wakefulness | 2022 |
Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases.
Topics: Aging; Alzheimer Disease; Amino Acid Sequence; Aminopyridines; Amyloid beta-Peptides; Animals; Apoptosis; Calcium; Cell Survival; Cells, Cultured; Glutamates; Molecular Sequence Data; Neurons; Neuroprotective Agents; Peptide Fragments; Prion Diseases; Prions; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Time Factors | 1998 |